Dr. Hoffman's laboratory showed that MPN myeloid cells secrete elevated levels of lipocalin-2, an inflammatory cytokine, and that lipocalin-2 levels are elevated in PMF patients [70]. This evidence concerns the gene LCN2 and myeloproliferative neoplasm.